$82.760
+9.733 (+11.76%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de TARS por análisis de gráficos similares
Alphio's TARS stock price prediction model matches the current Tarsus Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $82.37 (-0.47%). The 1-week path is $82.86 (+0.12%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Tarsus Pharmaceuticals Inc?
Tarsus Pharmaceuticals Inc is a good buy right now due to its strong financial performance, including a gross margin of 93% and a projected revenue increase with Q2 sales reaching $173.9 million. The stock is currently priced at $71.76, with analysts setting a price target of $100, indicating a potential upside of 39%. The main risk is the negative net income of $18.55 million reported in Q2 2026, which investors should monitor closely.
TARS cerró en $82.76 el Wednesday, tras subir +11.76%
Tarsus Pharmaceuticals Inc (TARS) last closed at $82.76, gaining +11.76%. These facts feed the 1-day and 1-week TARS price prediction above.
Factores de la previsión
Los factores de la previsión de Tarsus Pharmaceuticals Inc (TARS) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de TARS, ordenadas por similitud.
Análisis de estacionalidad de TARS
Historically the probability of a positive September return for TARS is 79.55%. October offers the highest probability of a positive month at 100.00%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de TARS
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Sep 2026 | $49.74 | $79.56 | $103.20 | -3.87% |
| Oct 2026 | $104.14 | $127.89 | $153.02 | +54.53% |
| Nov 2026 | $70.73 | $114.56 | $154.39 | +38.42% |
| Dec 2026 | $99.13 | $101.61 | $147.86 | +22.78% |
En 2026, se proyecta que Tarsus Pharmaceuticals Inc (TARS) oscile entre $49.74 y $154.39.
Previsión mensual de Tarsus Pharmaceuticals Inc para 2026
En Sep de 2026, se proyecta que Tarsus Pharmaceuticals Inc promedie $79.56, con un mínimo de $49.74 y un máximo de $103.20.
En Oct de 2026, se proyecta que Tarsus Pharmaceuticals Inc promedie $127.89, con un mínimo de $104.14 y un máximo de $153.02.
En Nov de 2026, se proyecta que Tarsus Pharmaceuticals Inc promedie $114.56, con un mínimo de $70.73 y un máximo de $154.39.
En Dec de 2026, se proyecta que Tarsus Pharmaceuticals Inc promedie $101.61, con un mínimo de $99.13 y un máximo de $147.86.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.